The objective of this work was to evaluate the safety and efficacy of a recombinant. subunit SARS-CoV-2 animal vaccine in cats against virulent SARS-CoV-2 challenge. Two groups of cats were immunized with two doses of either a recombinant SARS-CoV-2 spike protein vaccine or a placebo. administered three weeks apart. https://www.nacrack.com/hot-choice-Open-Box-Verona-Wig-by-BelleTress-Heat-Friendly-Synthetic-Hair-Average-Cap-Buttered-Toast-R-great-buy/